However, unlike known BPI, rCsBPI exhibits novel properties unreported previously, i.e. immunoregulatory effect and the ability to inhibit not only bacterial but also viral infection in vivo, though the effect on virus is likely an indirect one mediated by rCsBPI-induced antiviral immune response. Here, BPI is linked to viral infectious disease.